These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11150263)

  • 1. Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid.
    Elsing SH; Fekrat S; Green WR; Chang S; Wajer SD; Haller JA
    Ophthalmology; 2001 Jan; 108(1):45-8. PubMed ID: 11150263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
    Scott IU; Flynn HW; Murray TG; Feuer WJ;
    Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane.
    Scott IU; Murray TG; Flynn HW; Feuer WJ; Schiffman JC;
    Ophthalmology; 2002 Oct; 109(10):1828-33. PubMed ID: 12359602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.
    Loewenstein A; Humayun MS; de Juan E; Campochiaro PA; Haller JA
    Ophthalmology; 2000 Jun; 107(6):1078-82. PubMed ID: 10857826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foreign body response within postoperative perfluoro-N-octane for retinal detachment repair: clinical features, grading system, and histopathology.
    Sigler EJ; Randolph JC; Charles S
    Retina; 2014 Feb; 34(2):237-46. PubMed ID: 23881228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retained Intraocular Perfluoro-n-octane After Valved Cannula Pars Plana Vitrectomy for Retinal Detachment.
    Oellers P; Schneider EW; Fekrat S; Mahmoud TH; Mruthyunjaya P; Hahn P
    Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):451-6. PubMed ID: 25970866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane for the repair of giant retinal tears.
    Randolph JC; Diaz RI; Sigler EJ; Calzada JI; Charles S
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):253-7. PubMed ID: 25959143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative perfluoro-N-octane tamponade for primary retinal detachment repair.
    Rush R; Sheth S; Surka S; Ho I; Gregory-Roberts J
    Retina; 2012 Jun; 32(6):1114-20. PubMed ID: 21968506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and complications associated with perfluoro-n-octane and perfluoroperhydrophenanthrene in complex retinal detachment repair.
    Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ; Schiffman JC
    Ophthalmology; 2000 May; 107(5):860-5. PubMed ID: 10811075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25-gauge pars plana vitrectomy with medium-term postoperative perfluoro-n-octane tamponade for inferior retinal detachment.
    Sigler EJ; Randolph JC; Calzada JI; Charles S
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):34-40. PubMed ID: 23418732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye.
    Vote B; Wheen L; Cluroe A; Teoh H; McGeorge A
    Clin Exp Ophthalmol; 2003 Oct; 31(5):408-14. PubMed ID: 14516428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent retinal detachment more than 1 year after reattachment.
    Foster RE; Meyers SM
    Ophthalmology; 2002 Oct; 109(10):1821-7. PubMed ID: 12359601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorodecalin-induced intravitreal inflammation.
    Singh J; Ramaesh K; Wharton SB; Cormack G; Chawla HB
    Retina; 2001; 21(3):247-51. PubMed ID: 11421015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection.
    Han DP; Rychwalski PJ; Mieler WF; Abrams GW
    Am J Ophthalmol; 1994 Jul; 118(1):24-32. PubMed ID: 8023872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT characteristics of intraocular perfluoro-N-octane.
    Christoforidis JB; Caruso PA; Curtin HD; Fiore T; D'Amico DJ
    AJNR Am J Neuroradiol; 2003 Oct; 24(9):1769-71. PubMed ID: 14561600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal detachment in eyes undergoing pars plana vitrectomy for removal of retained lens fragments.
    Moore JK; Scott IU; Flynn HW; Smiddy WE; Murray TG; Kim JE; Vilar NF; Pereira MB; Jorge R
    Ophthalmology; 2003 Apr; 110(4):709-13; discussion 713-4. PubMed ID: 12689890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous inflammation and macular edema secondary to perfluoro-n-octane toxicity.
    Rodríguez-González F; Tejera-Santana M
    Rom J Ophthalmol; 2021; 65(2):180-182. PubMed ID: 34250315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment.
    Imaizumi A; Kusaka S; Noguchi H; Shimomura Y; Sawaguchi S
    Am J Ophthalmol; 2014 Feb; 157(2):384-389.e2. PubMed ID: 24332376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy.
    Glaser BM; Carter JB; Kuppermann BD; Michels RG
    Ophthalmology; 1991 Nov; 98(11):1613-21. PubMed ID: 1800921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluoro-N-octane (PFO) in the repair of complicated retinal detachments due to severe proliferative diabetic retinopathy.
    Maturi RK; Merrill PT; Lomeo MD; Diaz-Rohena R; Khan M; Lambert HM
    Ophthalmic Surg Lasers; 1999; 30(9):715-20. PubMed ID: 10574492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.